title: Lymphopenia induced by etanercept.
authors.affiliation: Department of Internal Medicine, University of South Florida Morsani College of Medicine and James A. Haley Veterans' Affairs Hospital, Tampa, Florida. Electronic address: apepper1@health.usf.edu.
authors.forename: Amber N
authors.initials: AN
authors.lastname: Pepper
authors.affiliation: Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine and James A. Haley Veterans' Affairs Hospital, Tampa, Florida.
authors.forename: Neetu
authors.initials: N
authors.lastname: Talreja
authors.affiliation: Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine and James A. Haley Veterans' Affairs Hospital, Tampa, Florida.
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Cowan
authors.affiliation: Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine and James A. Haley Veterans' Affairs Hospital, Tampa, Florida.
authors.forename: Mark C
authors.initials: MC
authors.lastname: Glaum
authors.affiliation: Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine and James A. Haley Veterans' Affairs Hospital, Tampa, Florida.
authors.forename: Richard F
authors.initials: RF
authors.lastname: Lockey
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy / Q000517:prevention & control; D008171:Lung Diseases / Q000188:drug therapy / Q000276:immunology; D008231:Lymphopenia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept